Summit Wealth Group (Colorado)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.16M Buy
4,437
+1,272
+40% +$326K 0.07% 150
2026
Q2
$797K Buy
3,165
+286
+10% +$61.5K 0.07% 154
2026
Q1
$626K Buy
2,879
+1,483
+106% +$329K 0.07% 153
2025
Q4
$319K Sell
1,396
-7,049
-83% -$1.61M 0.04% 204
2025
Q3
$1.26M Buy
8,445
+7,234
+597% +$1.47M 0.13% 135
2025
Q2
$225K Buy
+1,211
New +$225K 0.06% 221

Other funds holding ABBV

Summit Wealth Group (Colorado)'s ABBV Position: Q3 2026 in Review

Summit Wealth Group (Colorado) increased its AbbVie (ABBV) stake by 40% in Q3 2026, buying an estimated $326K and bringing the position to 4,437 shares worth $1.16M. The position accounts for 0.07% of the portfolio, ranked #150.

Summit Wealth Group (Colorado) first reported a position in ABBV in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.26M in Q3 2025. 4,257 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Summit Wealth Group (Colorado) held 4,437 shares of AbbVie worth $1.16M as of Q3 2026.
  • Summit Wealth Group (Colorado) bought 1,272 AbbVie shares in Q3 2026, an estimated $326K.
  • AbbVie made up 0.07% of Summit Wealth Group (Colorado)'s portfolio in Q3 2026, its #150 holding.
  • Summit Wealth Group (Colorado) first reported a position in AbbVie in Q2 2025 and has held it in 6 quarters since.
  • Summit Wealth Group (Colorado)'s AbbVie position peaked at $1.26M in Q3 2025.
  • 4,257 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Summit Wealth Group (Colorado)'s 13F filing for Q3 2026, filed 29 Oct 2026.